A major breakthrough in cancer study is emerging with the use of VHH fragments to re-engage damaged p53. This essential cancer inhibitor protein is frequently inactivated in several kinds of malignancies, causing https://bookmarksystem.com/story21752403/mini-antibodies-restore-tumor-suppressor-p53-a-potential-pathway-for-cancer-management